E2 treatment significantly increased the gene expression of HSD17B7 in both HD-treated healthy (~1.7-fold) and lipedema (~2-fold) ASCs compared to untreated control cells (Figure 4B). This evidence concerns the gene HSD17B7 and Lipedema.